Table 3 Most commonly adverse events occurred during the study period (> 2% of the subjects)
Adverse events | N | % of women |
|---|---|---|
Headache | 21 | 10.1 |
Spotting between menses | 9 | 4.3 |
Itching | 7 | 3.4 |
Nausea | 6 | 2.9 |
Breast pain | 6 | 2.9 |
Localised skin reaction | 6 | 2.9 |
Breast tension | 5 | 2.4 |